COPD: Page 10

Comorbidities lead to higher risk of prolonged ventilation in COPD patients
Study finds that risk is more than five times higher.
June 19, 2024
An older woman pictured with an oxygen mask receiving ventilation treatment.
Ensifentrine could add benefits for COPD patients
Evidence report suggests the treatment could work well when paired with other treatments.
June 19, 2024
Puzzle pieces forming a pair of lungs to represent lung treatment.
Simple exercise reduces COPD patients’ risk of hospitalization
Exercising on a treadmill can nearly cut in half one’s risk of being readmitted to the hospital.
June 13, 2024
Photo of feet in running shoes on a treadmill.
Sponsored
Pulmonary drug market forecast
Ascend Media
Review analysis, trends and predictions for pulmonary drug delivery systems, 2025 to 2034.
April 10, 2025
Pulmonary drug market forecast
Human trials begin in ultrasound system for COPD treatment
The first two patients are being tested in Tbilisi, Georgia, to confirm the safety of the platform.
June 13, 2024
Company Logo for AerWave Medical
FDA delays priority review of Dupixent by three months
A decision on the potential COPD treatment has been pushed back to September 2024.
June 5, 2024
A blue circle with FDA (Food and Drug Administration) printed on it.
Study unveils safe beta-blocker solution for COPD patients
Results presented at ATS 2024 show that bisoprolol can be prescribed to patients with COPD for cardiac disease treatment.
June 5, 2024
Image of a monitor showing patient vital signs.
Sponsored
CDC respiratory virus guidance
Ascend Media
Review recommendations and updates to help prevent illness.
April 10, 2025
CDC respiratory virus guidance
ATS 2024: ASLAN presents data on eblasakimab
Transitional data was presented on a head-to-head study of eblasakimab and dupilumab in a human tissue model.
May 30, 2024
Background image of stethoscope with graphics of charts and data in the foreground.
Fasenra could have potential for COPD
The FDA-approved asthma medication is currently in trials for additional uses.
May 30, 2024
Black doctor examining a tablet next to a microscope.
ATS 2024: Study takes race out of the equation
Spirometry clinical trial eligibility may differ with race-neutral equations.
May 23, 2024
Black male being tested with a spirometer.
Sponsored
Pulmonary drug market forecast
Ascend Media
Review analysis, trends and predictions for pulmonary drug delivery systems, 2025 to 2034.
April 10, 2025
Pulmonary drug market forecast
Tezspire shows promising potential for COPD treatment
Results from the phase 2a COURSE trial provide insight into the impact on COPD exacerbations.
May 23, 2024
Scientist using a digital tablet in a science lab.
Start-up aims to develop drugs for immunology and inflammation
Three hundred million in financing will go toward clinical trials for COPD and asthma treatments.
May 17, 2024
Image of inflammed human lungs.
COPD: A public health issue in rural communities
The CDC says rural residents face higher risks from COPD.
May 17, 2024
Graphic displaying statistics and information about COPD in rural communities.
Previous Page
Page 10 of 17
Next Page
Most Popular
GINA releases 2025 asthma guidelines update
Brinsupri becomes first FDA-approved therapy for NCFB
Alternative inflammatory pathways drive residual asthma exacerbations in children treated with mepolizumab
Zinc’s emerging role in pediatric asthma, allergic rhinitis
Concerns mount over Singulair
Researchers create 3D-printed living lung tissue